183 related articles for article (PubMed ID: 32498630)
1. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety.
Guo J; Arellano RS
J Endourol; 2020 Oct; 34(10):1021-1027. PubMed ID: 32498630
[No Abstract] [Full Text] [Related]
2. Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors.
Guo J; Arellano RS
AJR Am J Roentgenol; 2021 Jan; 216(1):117-124. PubMed ID: 32603227
[No Abstract] [Full Text] [Related]
3. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
4. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
[TBL] [Abstract][Full Text] [Related]
5. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.
Chlorogiannis DD; Kratiras Z; Efthymiou E; Moulavasilis N; Kelekis N; Chrisofos M; Stravodimos K; Filippiadis DK
Cardiovasc Intervent Radiol; 2024 May; 47(5):573-582. PubMed ID: 38561521
[TBL] [Abstract][Full Text] [Related]
7. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
8. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.
Ierardi AM; Puliti A; Angileri SA; Petrillo M; Duka E; Floridi C; Lecchi M; Carrafiello G
Med Oncol; 2017 May; 34(5):97. PubMed ID: 28421553
[TBL] [Abstract][Full Text] [Related]
9. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
Shakeri S; Afshari Mirak S; Mohammadian Bajgiran A; Pantuck A; Sisk A; Ahuja P; Lu DS; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2308-2315. PubMed ID: 30847565
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
11. Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned.
Thompson SM; Schmitz JJ; Thompson RH; Weisbrod AJ; Welch BT; Viers BR; Hannon JD; Schmit GD; Atwell TD; Kurup AN
AJR Am J Roentgenol; 2018 Dec; 211(6):1381-1389. PubMed ID: 30247980
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous microwave ablation for local control of metastatic renal cell carcinoma.
Maciolek KA; Abel EJ; Best SL; Emamekhoo H; Averill SL; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Wells SA
Abdom Radiol (NY); 2018 Sep; 43(9):2446-2454. PubMed ID: 29464274
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes.
Gunn AJ; Joe WB; Salei A; El Khudari H; Mahmoud KH; Bready E; Keasler EM; Patten PP; Gordetsky JB; Rais-Bahrami S; Abdel Aal AK
Cardiovasc Intervent Radiol; 2019 Jul; 42(7):970-978. PubMed ID: 31044292
[TBL] [Abstract][Full Text] [Related]
14. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
Zhou W; Herwald SE; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
[TBL] [Abstract][Full Text] [Related]
15. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.
Shapiro DD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Jarrard DF; Richards KA; Downs TM; Allen GO; Nakada SY; Abel EJ
Urology; 2020 Jan; 135():88-94. PubMed ID: 31585198
[TBL] [Abstract][Full Text] [Related]
16. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH
Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
19. An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma.
Wu J; Sami S; Lajkosz K; Kishibe T; Ordon M
J Endourol; 2023 Dec; 37(12):1314-1330. PubMed ID: 37819699
[No Abstract] [Full Text] [Related]
20. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores.
Efthymiou E; Velonakis G; Charalampopoulos G; Mazioti A; Brountzos E; Kelekis N; Filippiadis D
Eur Radiol; 2023 Nov; 33(11):7388-7397. PubMed ID: 37318604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
